Clinical Trial: Mesenchymal Stem Cells With Therapeutic Hypothermia for Infants With Perinatal Hypoxic-Ischemic Encephalopathy

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018739) titled 'Mesenchymal Stem Cells With Therapeutic Hypothermia for Infants With Perinatal Hypoxic-Ischemic Encephalopathy' on June 04.

Brief Summary: Perinatal hypoxic-ischemic encephalopathy (HIE) remains a significant cause of neonatal morbidity and mortality. While therapeutic hypothermia (TH) has been established as the standard treatment, many infants continue to experience adverse neurodevelopmental outcomes. Mesenchymal stem cells (MSCs), known for their neuroprotective, anti-inflammatory, and regenerative properties, offer a promising adjunctive therapy.

The goal of this study is to evaluate the safety and feasibility of administering...